Skip to content
Screener

Thermo Fisher Scientific TMO North America — Consolidated revenues

Other geography segments

Europe
$2.96B+12.7%
Asia-Pacific
$1.97B+4.2%
Other regions
$372M+10.4%

Similar metrics at other companies

Dream Finders Homes logo
DFHFinancial Services — Consolidated revenues
$51.18M+159%
Coherent logo
COHRNorth America — Revenue
$1.16B+23.3%
Planet Labs logo
PLNorth America — Revenue
$37.04M+25.4%
Ubiquiti Inc. logo
UINorth America — Revenue
$410.21M+27.1%
AMC Robotics Corporation logo
AMCINorth America — Revenue
$1.18M-2.5%
CVD Equipment Corp. logo
CVVNorth America — Revenue
$1K-66.7%

Other financials

Income statement

See full
Revenue$12.0B—
Operating income$2.1B—
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$221.73B+27.0%
Enterprise value$256.85B+23.8%
P/E31.8×+5.3×
P/S5×-1.0×

Profitability

See full
Gross margin58.3%—
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)Three months ended / March 28, 2026March 29, 2025
Revenues
North America$5,705$5,513
Europe2,9572,624
Asia-Pacific1,9701,891
Other regions372337
Consolidated revenues$11,005$10,364

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's north america — consolidated revenues?
Thermo Fisher Scientific (TMO) reported north america — consolidated revenues of $5.71B in Q1 2026.
How has Thermo Fisher Scientific's north america — consolidated revenues changed year-over-year?
Thermo Fisher Scientific's north america — consolidated revenues increased by 3.5% year-over-year, from $5.51B to $5.71B.
What is the long-term trend for Thermo Fisher Scientific's north america — consolidated revenues?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's north america — consolidated revenues has grown at a 4.0% compound annual growth rate (CAGR), from $19.66B to $23.03B.
What does north america — consolidated revenues mean?
This metric represents the total gross sales generated by the company within the North American geographic region. It encompasses all revenue streams from products, services, and solutions sold to customers located in this specific market. Tracking this figure helps stakeholders assess the company's market penetration, regional demand trends, and the overall health of its primary operational territory.

Ask your AI about Thermo Fisher Scientific's north america — consolidated revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude